Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Tomoya Kuda"'
Autor:
Eisaku Miyauchi, Hisashi Tanaka, Atsushi Nakamura, Toshiyuki Harada, Taku Nakagawa, Mami Morita, Daisuke Jingu, Tomoya Kuda, Shunichi Gamou, Ryota Saito, Akira Inoue
Publikováno v:
Thoracic Cancer, Vol 12, Iss 21, Pp 2886-2893 (2021)
Abstract Background NJLCG1402 was a phase I/II trial investigating biweekly nanoparticle albumin‐bound paclitaxel (nab‐PTX) in patients with advanced non‐small cell lung cancer (NSCLC). Methods The study included patients aged ≥20 years with
Externí odkaz:
https://doaj.org/article/1d2e818515ca48b8833458e79cf91807
Autor:
Kazuki Sugata, Koichiro Kajiura, Haruki Taniguchi, Tomoya Kuda, Akiko Matsuzaki, Taizo Fukumoto
Publikováno v:
Respirology Case Reports, Vol 9, Iss 9, Pp n/a-n/a (2021)
Abstract Ectopic pancreas (EP) is typically found within other gastrointestinal organs. Its discovery in other parts of the body, especially in the mediastinum, is exceedingly rare. This paper presents a case of a 17‐year‐old female patient with
Externí odkaz:
https://doaj.org/article/5acc135149d54d69b7f47a9d6efb48a2
Autor:
Yukihiro Toi, Takao Kobayashi, Toshiyuki Harada, Taku Nakagawa, Yoshiaki Mori, Tomoya Kuda, Shunichi Sugawara
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundDiarrhea post-antibiotic use is primarily attributed to mucosal lesions induced by Clostridium (Clostridioides) difficile (C. difficile) infection (CDI). Cancer patients undergoing chemotherapy might have a higher risk of CDI even when prio
Externí odkaz:
https://doaj.org/article/5c601ce2fb1d4ab2aa934bf7c791d5b2
Autor:
Toshiyuki Harada, Daisuke Jingu, Mami Morita, Akira Inoue, Hisashi Tanaka, Atsushi Nakamura, Shunichi Gamou, Taku Nakagawa, Eisaku Miyauchi, Ryota Saito, Tomoya Kuda
Publikováno v:
Thoracic Cancer, Vol 12, Iss 21, Pp 2886-2893 (2021)
Thoracic Cancer
Thoracic Cancer
Background NJLCG1402 was a phase I/II trial investigating biweekly nanoparticle albumin‐bound paclitaxel (nab‐PTX) in patients with advanced non‐small cell lung cancer (NSCLC). Methods The study included patients aged ≥20 years with previousl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8332947eb31856090e9172abea5bfa3
https://doaj.org/article/1d2e818515ca48b8833458e79cf91807
https://doaj.org/article/1d2e818515ca48b8833458e79cf91807
Autor:
Yosuke Kawashima, Tomoya Kuda, Kana Watanabe, Kazuhiro Usui, Kei Takamura, Shunichi Sugawara, Taku Nakagawa, Yuka Fujita, Akimasa Sekine, Akira Inoue, Kenya Kanazawa, Toshiyuki Harada, Naoto Morikawa
Publikováno v:
International Journal of Clinical Oncology. 26:515-522
A subset analysis of the CA031 trial showed significant improvement in the overall response rate after administration of carboplatin plus weekly albumin-bound paclitaxel compared to carboplatin plus paclitaxel for squamous cell carcinoma of the lung
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a44e1fa8ce504d85a856987e7b98b515
https://doi.org/10.1007/s10147-020-01828-1
https://doi.org/10.1007/s10147-020-01828-1
Autor:
Taku Nakagawa, Shunichi Sugawara, Yoshiaki Mori, Takao Kobayashi, Yukihiro Toi, Toshiyuki Harada, Tomoya Kuda
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
BackgroundDiarrhea post-antibiotic use is primarily attributed to mucosal lesions induced by Clostridium (Clostridioides) difficile (C. difficile) infection (CDI). Cancer patients undergoing chemotherapy might have a higher risk of CDI even when prio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c6dadbc04f22d3b874ab6a3e753b9af
http://europepmc.org/articles/PMC8320591
http://europepmc.org/articles/PMC8320591
Autor:
Kazuhiro Usui, Kana Watanabe, Naoto Morikawa, Akira Inoue, Yosuke Kawashima, Kenya Kanazawa, Taku Nakagawa, Shunichi Sugawara, Kei Takamura, Yuka Fujita, Akimasa Sekine, Tomoya Kuda, Toshiyuki Harada
Publikováno v:
Annals of Oncology. 30:vi107
Background The subset analysis of CA031 trial showed a significant improvement of overall response rate (ORR) for carboplatin (CBDCA) plus weekly nab-paclitaxel (CnP) versus CBDCA plus paclitaxel in patients (pts) with squamous cell histology (41% vs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f3f95a8652684d96c8d4ed1af5c3f02
https://doi.org/10.1093/annonc/mdz338.073
https://doi.org/10.1093/annonc/mdz338.073
Autor:
Satoshi Oizumi, Fumihiro Hommura, Tomoya Kuda, Masaharu Nishimura, K. Ito, Yutaka Katsuura, Kei Takamura, Aya Suzuki, Makoto Maemondo, Yuka Fujita, Hirotoshi Dosaka-Akita, Eiki Kikuchi, Shunichi Sugawara, Toshiyuki Harada, Ichiro Kinoshita, Akira Inoue, Hiroshi Isobe
Publikováno v:
The Oncologist. 18:439-445
Amrubicin, a third-generation synthetic anthracycline agent, has favorable clinical activity and acceptable toxicity for the treatment of patients with non-small cell lung cancer (NSCLC) and small cell lung cancer. We conducted this study to evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73ff8d12bf1c72903611da2a832fd3df
https://doi.org/10.1634/theoncologist.2012-0308
https://doi.org/10.1634/theoncologist.2012-0308
Autor:
Kodai, Kawamura, Kazuya, Ichikado, Hiroyuki, Muranaka, Yasuhiro, Gushima, Norihiro, Iwamoto, Makoto, Takaki, Tomoya, Kuda, Mitsuko, Honda, Naoko, Arakawa, Moritaka, Suga
Publikováno v:
Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society. 48(4)
Since more solid malignancies are observed in transplant recipients treated with cyclosporine (CsA) than in healthy persons. We sought to describe the incidence of malignancy in patients treated with CsA for fibrosing interstitial pneumonia.We prospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5dd5562e8ee512f1c7c902b60b22af0a
https://pubmed.ncbi.nlm.nih.gov/20432965
https://pubmed.ncbi.nlm.nih.gov/20432965
Autor:
Yousuke Kawashima, Keito Okazaki, Tatsuhiko Koizumi, Tomoya Kuda, Yukihiro Toi, Yoshihiro Honda, Akiko Tanaka, Shunichi Sugawara, Takao Kobayashi, Masatoshi Takahara, Osamu Ishimoto
Publikováno v:
Journal of Clinical Oncology. 30:e19521-e19521
e19521 Background: Diarrhea after antibiotic treatment is primarily ascribed to the development of mucosal lesion for which Clostridium difficile infection (CDI) is held responsible. Evidence on CDI in patients on chemotherapy without antibiotic trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cc78b5cfde6c6a1451e685fce0eb28e
https://doi.org/10.1200/jco.2012.30.15_suppl.e19521
https://doi.org/10.1200/jco.2012.30.15_suppl.e19521